SALL4 in gastrointestinal tract cancers: upstream and downstream regulatory mechanisms

Tairan Wang1, Yan Jin1, Mengyao Wang2

  • 1School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, 453003, China.

Insights

SALL4, a stem cell factor, is overexpressed in gastrointestinal tract (GIT) cancers, driving tumorigenesis. Targeting SALL4-related pathways may offer new therapeutic strategies for these challenging cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • Gastrointestinal tract (GIT) cancers present significant challenges in effective treatment and early diagnosis.
  • SALL4, a key transcription factor in embryonic development, regulates cell proliferation, survival, migration, and stem cell function.
  • SALL4 overexpression is linked to tumorigenesis, but its specific role and mechanisms in GIT cancers remain largely unelucidated.

Purpose of the Study:

  • To elucidate the functions of SALL4 in various gastrointestinal tract cancers.
  • To identify upstream/downstream genes and signaling pathways regulated by SALL4 in the context of GIT cancers.
  • To explore the potential of targeting SALL4-associated genes or pathways for novel therapeutic interventions in GIT cancers.

Main Methods:

  • Literature review and analysis of existing studies on SALL4.
  • Examination of SALL4's role in cell proliferation, survival, migration, and stemness.
  • Discussion of upstream/downstream molecular targets and signaling pathways implicated in SALL4-driven GIT tumorigenesis.

Main Results:

  • SALL4 plays a significant role in the development and progression of gastrointestinal tract cancers.
  • Overexpression of SALL4 is associated with tumorigenesis and altered cellular functions relevant to cancer.
  • Specific genes and pathways influenced by SALL4 in different GIT cancers have been identified.

Conclusions:

  • SALL4 is implicated as a critical factor in gastrointestinal tract cancers.
  • Understanding SALL4's regulatory network provides insights into GIT cancer mechanisms.
  • Targeting SALL4 or its associated pathways presents a promising avenue for developing novel GIT cancer therapies.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.4K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K